TY  - BOOK
AU  - Seca, Ana M. L
AU  - Pinto, Diana Cláudia
AB  - Many macro and micro species, from terrestrial and aquatic environments, produce structurally unique compounds and, in many countries, still are the primary sources of medicines. In fact, secondary metabolites are an important source of chemotherapeutic agents but are also lead compounds for synthetic modification and the optimization of biological activity. Therefore, the exploitation of secondary metabolites, or their inspired synthetic compounds, offers excellent opportunities for the pharmaceutical industry. This Medicines Special Issue focuses on the great potential of secondary metabolites for therapeutic application. The Special Issue contains 16 articles reporting relevant experimental results, and an overview of bioactive secondary metabolites, their biological effects, and new methodologies that improve and accelerate the process of obtained lead compounds with regard to new drug development. We would like to thank all 83 authors, from all over the world, for their valuable contributions to this Special Issue.
DO  - 10.3390/books978-3-03921-188-3
ID  - OAPEN ID: 35928
KW  - antitumor
KW  - triterpenoids
KW  - seaweeds
KW  - diterpenes
KW  - Boswellia
KW  - antioxidant activity
KW  - antiplasmodial
KW  - Maytenus chiapensis
KW  - phenolic derivatives
KW  - secondary metabolites
KW  - medicinal applications
KW  - Malus x domestica
KW  - pectin
KW  - cytotoxic activity
KW  - xanthine oxidase
KW  - phytochemistry
KW  - antioxidant
KW  - Scabiosa
KW  - sugars
KW  - sargaquinoic acid
KW  - pentacyclic triterpenoids
KW  - analysis
KW  - antimicrobial and anticancer activity
KW  - iridoids
KW  - Tuscany
KW  - GC-MS
KW  - (-)-rabdosiin
KW  - kratom
KW  - plant defense
KW  - cembranoids
KW  - tingenone
KW  - deoxypodophyllotoxin
KW  - anticancer
KW  - pristimerin
KW  - inflammation
KW  - boswellic acids
KW  - plants
KW  - anti-inflammatory
KW  - legalization
KW  - Mitragyna speciosa
KW  - Ocimum sanctum
KW  - cordycepin
KW  - cytotoxic
KW  - medicine
KW  - Artemisia species
KW  - antimicrobial activity
KW  - lignans
KW  - Artemisia vachanica
KW  - Cordyceps militaris
KW  - frankincense
KW  - ancient varieties
KW  - sargahydroquinoic acid
KW  - Tajikistan
KW  - antiSMASH
KW  - ABTS
KW  - polyphenols
KW  - therapeutics
KW  - infectious diseases
KW  - antibacterial
KW  - nutraceutics
KW  - total phenolics
KW  - LC-MS/MS
KW  - innate immunity
KW  - HPLC-PAD
KW  - sarganaphthoquinoic acid
KW  - biosynthetic gene clusters
KW  - DPPH
KW  - EGCG
KW  - cneorubenoids
KW  - PPAR-?
KW  - bowel diseases
KW  - amentoflavone
KW  - molecular docking
KW  - sargachromenoic acid
KW  - cannabinoids
KW  - flavonoids
KW  - essential oils
KW  - TCM
KW  - HPLC-PDA
KW  - ascorbic acid
KW  - antioxidants
KW  - Lamiaceae
KW  - nanoemulsion
KW  - malaria
KW  - therapeutic uses
KW  - quinonemethide triterpenoids
KW  - artemisinin
KW  - natural products
KW  - biological activities
KW  - FRAP
KW  - toxicology
KW  - defensins
KW  - Celastraceae
KW  - cannabis
KW  - vector control
KW  - Juniperus
KW  - analytical determination
L1  - https://mdpi.com/books/pdfview/book/1452
LA  - English
LK  - https://directory.doabooks.org/handle/20.500.12854/42231
PB  - MDPI - Multidisciplinary Digital Publishing Institute
PY  - 2019
SN  - 9783039211883
SN  - 9783039211876
TI  - Biological Potential and Medical Use of Secondary Metabolitesnull
ER  - 
